Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引：0
|
作者：
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源：
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词：
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [21] Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients (vol 20, pg 393, 2016)
    Wakamiya, Takuya
    Hokosaki, Tatsunori
    Tsujimoto, Shin-ichi
    Kadota, Keisuke
    Nakano, Yusuke
    Watanabe, Shigeo
    Iwamoto, Mari
    Yanagimachi, Masakatsu
    Ito, Shuichi
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (05) : 501 - 501
  • [22] Genetic polymorphisms of VKORC1, CYP2C9, CYP4F2 in Bai, Tibetan Chinese
    Zeng, W. T.
    Zheng, Q. S.
    Huang, M.
    Cen, H. J.
    Lai, Y.
    Chen, W. Y.
    Zhao, L. Z.
    Leng, X. Y.
    PHARMAZIE, 2012, 67 (01): : 69 - 73
  • [23] Effects of CYP4F2 and GGCX genetic variants on maintenance warfarin dose in a multiethnic Asian population
    Chan, Sze Ling
    Goh, Boon Cher
    Chia, Kee Seng
    Chuah, Benjamin
    Wong, Andrea
    Lim, Robert
    Lee, Soo Chin
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 1100 - 1102
  • [24] Warfarin Pharmacogenetics: Polymorphisms of the CYP2C9, CYP4F2, and VKORC1 Loci in a Genetically Admixed Omani Population
    Pathare, Anil V.
    Al Zadjali, Shoaib
    Misquith, Rhea
    Alkindi, Salam S.
    Panjwani, Vinodh
    Lapoumeroulie, Claudine
    Pravin, Sahaya
    Paldi, Andras
    Krishnamoorthy, Rajagopal
    HUMAN BIOLOGY, 2012, 84 (01) : 67 - 77
  • [25] Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX
    Fohner, Alison E.
    Robinson, Renee
    Yracheta, Joseph
    Dillard, Denise A.
    Schilling, Brian
    Khan, Burhan
    Hopkins, Scarlett
    Boyer, Bert B.
    Black, Jynene
    Wiener, Howard
    Tiwari, Hemant K.
    Gordon, Adam
    Nickerson, Deborah
    Tsai, Jesse M.
    Farin, Federico M.
    Thornton, Timothy A.
    Rettie, Allan E.
    Thummel, Kenneth E.
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (07): : 343 - 353
  • [26] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Farajzadeh-Dehkordi, Mahvash
    Samiee-Rad, Fatemeh
    Farzam, Seyed Saeed
    Javadi, Amir
    Cheraghi, Sara
    Hamedi-Asl, Dariush
    Rahmani, Babak
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 695 - 704
  • [27] Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
    Fung, Erik
    Patsopoulos, Nikolaos A.
    Belknap, Steven M.
    O'Rourke, Daniel J.
    Robb, John F.
    Anderson, Jeffrey L.
    Shworak, Nicholas W.
    Moore, Jason H.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2012, 38 (08): : 893 - 904
  • [28] Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
    Flockhart, David A.
    O'Kane, Dennis
    Williams, Marc S.
    Watson, Michael S.
    Flockhart, David A.
    Gage, Brian
    Gandolfi, Roy
    King, Richard
    Lyon, Elaine
    Nussbaum, Robert
    O'Kane, Dennis
    Schulman, Kevin
    Veenstra, David
    Williams, Marc S.
    Watson, Michael S.
    GENETICS IN MEDICINE, 2008, 10 (02) : 139 - 150
  • [29] Pharmacogenetic Impact of VKORC1 and CYP2C9 Allelic Variants on Warfarin Dose Requirements in a Hispanic Population Isolate
    Palacio, Lina
    Falla, Diana
    Tobon, Ignacio
    Mejia, Fernando
    Lewis, John E.
    Martinez, Ariel F.
    Arcos-Burgos, Mauricio
    Camargo, Mauricio
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2010, 16 (01) : 83 - 90
  • [30] Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients
    Sripriya Natarajan
    Chandrashekhar K. Ponde
    Rajesh M. Rajani
    Farah Jijina
    Roopkumar Gursahani
    Pradnya P. Dhairyawan
    Tester F. Ashavaid
    Pharmacological Reports, 2013, 65 : 1375 - 1382
12345